Nomura Micro Science Co., Ltd. (6254) AI Stock Analysis

• Market Cap: ¥110.74B
• Dividend Yield: 2.87%
• Average Volume (3M): 755.66K
• Price to Earnings (P/E): 9.1
• Beta (1Y): 1.45
• Revenue Growth: 89.90%
• EPS Growth: 190.48%
• Country: JP
• Employees: 545
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): 24.99
• Shares Outstanding: 40,608,000
• 10 Day Avg. Volume: 795,700
• 30 Day Avg. Volume: 755,656
• PEG Ratio: 0.33
• Price to Book (P/B): 2.45
• Price to Sales (P/S): 0.94
• P/FCF Ratio: -4.06
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,500.00
• Price Target Upside: -10.46% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 65 Neutral
• Price Target: ¥3,370.00 ▲(20.70% Upside)

The overall stock score for Nomura Micro Science Co., Ltd. is driven primarily by its strong financial performance and attractive valuation. However, bearish technical indicators suggest caution, as the stock is currently in a downward trend. Investors should monitor cash flow improvements and technical signals for potential entry points.

Positive Factors

Revenue Growth

Strong revenue growth indicates increasing demand for the company's products, suggesting successful market penetration and expansion opportunities.

Profit Margins

Improved profit margins reflect effective cost management and operational efficiency, strengthening the company's long-term profitability.

Market Position

Strategic partnerships with major firms bolster market position and provide access to new markets, supporting sustained growth.

Negative Factors

Cash Flow Challenges

Negative cash flow can limit the company's ability to invest in growth and meet financial obligations, impacting long-term sustainability.

Debt Levels

Rising debt levels may strain financial resources and increase risk, potentially affecting future financial stability and flexibility.

Cash Management

Improving cash management is crucial for sustaining growth and ensuring the company can capitalize on future opportunities effectively.

Nomura Micro Science Co., Ltd. Business Overview & Revenue Model

Company Description

Nomura Micro Science Co., Ltd. engages in the design, installation, and sale of water treatment technologies in Japan, South Korea, Taiwan, China, and the United States. The company offers water treatment plants and equipment, including pure and ultra-pure water systems, pharmaceutical water production systems, wastewater treatment systems, and water reclamation systems. It also provides pretreatment systems, heat regenerative type membrane filtration equipment, coagulating sedimentation equipment, flocculation filtration, gravity filtration, and pressure filtration equipment, electrodeionization, ion exchange systems, reverse osmosis (RO) systems, vacuum and membrane degasifier, pure steam generators, package type purified water production systems, WFI production systems, ozone and hydrogen water production systems, and anti-static equipment. In addition, it offers return contamination monitor, H2O2 monitor, nuclepore membrane, filter cartridge, and piping and environmental materials; and site supply of pure water, and water analysis and evaluation services on a contract basis. The company serves electronics, pharmaceutical, biotechnology, food, environment and energy, and analysis industries. Nomura Micro Science Co., Ltd. was founded in 1969 and is headquartered in Atsugi, Japan.

How the Company Makes Money

Nomura Micro Science generates revenue primarily through the sale of its micro-precision components and systems to a diverse range of industries. Key revenue streams include direct sales to manufacturers in the electronics and telecommunications sectors, as well as partnerships with medical device companies for custom micro-engineered solutions. The company also engages in research and development collaborations, which may lead to additional funding and revenue opportunities through grants or joint ventures. Significant partnerships with leading technology firms enhance its market presence and contribute to its earnings by providing access to new markets and customers.

Nomura Micro Science Co., Ltd. Financial Statement Overview

Summary

Nomura Micro Science Co., Ltd. demonstrates robust financial performance with strong revenue and profit growth. The balance sheet reflects financial stability, but the company must focus on improving cash flow generation to support long-term objectives. Overall, the financial health is sound, with opportunities to enhance cash management.

Income Statement

Nomura Micro Science Co., Ltd. has exhibited strong revenue growth, with a notable increase in total revenue from 2024 to 2025. Gross profit and net profit margins have improved, indicating enhanced operational efficiency and profitability. The EBIT and EBITDA margins are solid, reflecting effective cost management and a healthy earnings profile.

Balance Sheet

The company's balance sheet shows a moderate debt-to-equity ratio, suggesting a balanced approach to leveraging. The return on equity is strong, driven by rising net income and shareholder equity. The equity ratio indicates a stable financial structure, though the increase in total debt in recent years warrants attention.

Cash Flow

The cash flow analysis reveals challenges, with negative free cash flow and operating cash flow over the recent periods. However, there is a significant improvement in free cash flow from 2024 to 2025. The company needs to address cash flow generation to ensure sustainable growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	101.13B	96.36B	73.02B	49.60B	31.90B	30.36B
Gross Profit	22.16B	21.11B	15.41B	10.37B	7.66B	7.13B
EBITDA	17.90B	16.95B	11.72B	7.70B	4.78B	3.77B
Net Income	10.25B	10.20B	7.98B	5.81B	3.29B	2.62B
Balance Sheet
Total Assets	103.87B	116.78B	70.60B	41.92B	27.09B	24.76B
Cash, Cash Equivalents and Short-Term Investments	18.89B	17.33B	12.14B	14.12B	10.08B	9.86B
Total Debt	47.98B	53.20B	22.40B	3.47B	2.69B	2.63B
Total Liabilities	68.92B	79.77B	41.68B	20.52B	11.16B	11.57B
Stockholders Equity	34.95B	37.01B	28.92B	21.40B	15.93B	13.19B
Cash Flow
Free Cash Flow	0.00	-22.31B	-19.02B	3.65B	771.34M	5.80B
Operating Cash Flow	0.00	-18.73B	-18.66B	4.68B	1.13B	5.96B
Investing Cash Flow	0.00	-2.74B	386.99M	64.81M	134.01M	-433.48M
Financing Cash Flow	0.00	27.18B	17.45B	-24.90M	-881.82M	-937.84M

Nomura Micro Science Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 2792.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6254, the sentiment is Neutral. The current price of 2792 is below the 20-day moving average (MA) of 2827.50, below the 50-day MA of 3305.78, and above the 200-day MA of 2778.62, indicating a neutral trend. The MACD of -176.25 indicates Negative momentum. The RSI at 43.05 is Neutral, neither overbought nor oversold. The STOCH value of 59.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:6254.

Nomura Micro Science Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6482	74 Outperform	¥24.34B	19.28	―	2.80%	-4.47%	-24.47%
6340	71 Outperform	¥95.04B	10.76	―	2.62%	8.65%	-23.00%
6486	69 Neutral	¥138.92B	18.56	―	3.89%	1.70%	18.50%
6284	68 Neutral	¥90.58B	11.95	―	3.24%	18.70%	33.93%
6490	67 Neutral	¥111.84B	13.32	―	2.50%	-2.46%	-10.72%
6254	65 Neutral	¥110.74B	9.13	―	2.87%	89.90%	190.48%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%

Nomura Micro Science Co., Ltd. Corporate Events

Nomura Micro Science Reports Robust Financial Growth in 2025

Nomura Micro Science Co., Ltd. reported significant financial growth for the six months ending September 30, 2025, with a 39.6% increase in net sales and an 84.3% rise in operating profit compared to the previous year. This robust performance underscores the company’s strong market positioning and operational efficiency, indicating positive implications for stakeholders and a promising outlook for the fiscal year ending March 31, 2026.

Nomura Micro Science Revises Q2 FY2026 Earnings Forecast Amid Project Progress

Nomura Micro Science Co., Ltd. has revised its consolidated earnings forecast for the second quarter of FY2026, anticipating higher sales revenue and profits due to accelerated progress in water treatment projects in Japan and the US. Despite delays in other regions, cost reductions have significantly boosted operating profits. The company maintains its full-year forecast but acknowledges potential fluctuations in project timelines that may necessitate future revisions.